Vikram Karnani

Vikram Karnani

President and Chief Executive OfficeratCollegium Pharmaceutical· In proxies 2022–2025

Pay in FY2025-84% from the year before · Collegium Pharmaceutical stock +61.6% the same year

Vikram Karnani was paid $1.7M in FY2025 (Dec), down 84%. Collegium Pharmaceutical stock rose 61.6% that year.

Pay$100 in the stock at the end of FY21 → $248
Pay is from the Summary Compensation Table of each Collegium Pharmaceutical proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Collegium PharmaceuticalPublic company · 4 yr
    • President and Chief Executive Officer2022 – Present · 4 yrStock in role +17%
  2. Dyne Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?